News

Shares of Novavax Inc. NVAX shed 3.23% to $6.00 Thursday, on what proved to be an all-around dismal trading session for the ...
One of the FDA’s recently departed top officials is weighing in on the wide-ranging staff cuts at the agency and how they ...
Bank of America Securities analyst Alec Stranahan maintained a Hold rating on Novavax (NVAX – Research Report) today and set a price target of ...
In a report released today, Alec Stranahan from Bank of America Securities maintained a Buy rating on Agios Pharma (AGIO – Research Report), ...
Shares of several vaccine makers soared after reports suggest that the Biden administration is in discussions with Moderna MRNA and Pfizer PFE to set up a possible vaccine program aimed at preventing ...
The health secretary is frequently returning to rhetoric from his time as one of the nation's most prominent vaccine critics.
Brian Ballard and his powerful lobbying firm, Ballard Partners, are cashing in bigtime in the second Trump presidency. They’re inking deals with foreign governments, mega-corporations in the fossil ...
Among the 25.1% of participants who said they experienced long-COVID symptoms, 12.8% reported sleeping disorders.
The study authors say the findings highlight the complex and multifaceted nature of antibiotic resistance in group B strep.
The HHS chief, who has long argued that vaccines cause autism, dismissed the notion that "better diagnoses, better recognition, or changing diagnostic criteria" are driving up figures. Also, the CDC's ...